Clinical Trials Directory

Trials / Completed

CompletedNCT02935088

PRESSUREwire Study

Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures

Status
Completed
Phase
Study type
Observational
Enrollment
2,217 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.

Detailed description

The purpose of this study is to understand routine use of FFR and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures. The study will also collect data on the routine use of coronary physiologic measurements such as adenosine-induced hyperemia FFR, FFR by contrast-induced hyperemia,

Conditions

Interventions

TypeNameDescription
DEVICEFractional Flow ReserveMeasurement of physiologic parameters

Timeline

Start date
2016-10-12
Primary completion
2019-03-22
Completion
2019-03-22
First posted
2016-10-17
Last updated
2020-02-07
Results posted
2020-02-07

Locations

71 sites across 15 countries: United States, Austria, Canada, Egypt, Estonia, Germany, Greece, India, Italy, Japan, Netherlands, Portugal, Saudi Arabia, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT02935088. Inclusion in this directory is not an endorsement.